Akoya Biosciences (AKYA) Competitors $1.37 +0.02 (+1.41%) Closing price 07/3/2025 02:39 PM EasternExtended Trading$1.37 +0.01 (+0.37%) As of 07/3/2025 04:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AKYA vs. QTRX, FEIM, RPID, SEER, OWLT, PRE, KEQU, NAUT, INTT, and ODYSShould you be buying Akoya Biosciences stock or one of its competitors? The main competitors of Akoya Biosciences include Quanterix (QTRX), Frequency Electronics (FEIM), Rapid Micro Biosystems (RPID), Seer (SEER), Owlet (OWLT), Prenetics Global (PRE), Kewaunee Scientific (KEQU), Nautilus Biotechnology (NAUT), inTEST (INTT), and Odysight.ai (ODYS). These companies are all part of the "measuring and control equipment" industry. Akoya Biosciences vs. Its Competitors Quanterix Frequency Electronics Rapid Micro Biosystems Seer Owlet Prenetics Global Kewaunee Scientific Nautilus Biotechnology inTEST Odysight.ai Akoya Biosciences (NASDAQ:AKYA) and Quanterix (NASDAQ:QTRX) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, media sentiment, risk and profitability. Does the media prefer AKYA or QTRX? In the previous week, Akoya Biosciences' average media sentiment score of 0.00 equaled Quanterix'saverage media sentiment score. Company Overall Sentiment Akoya Biosciences Neutral Quanterix Neutral Do institutionals & insiders believe in AKYA or QTRX? 79.4% of Akoya Biosciences shares are owned by institutional investors. Comparatively, 86.5% of Quanterix shares are owned by institutional investors. 7.3% of Akoya Biosciences shares are owned by company insiders. Comparatively, 6.9% of Quanterix shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has higher earnings and valuation, AKYA or QTRX? Quanterix has higher revenue and earnings than Akoya Biosciences. Quanterix is trading at a lower price-to-earnings ratio than Akoya Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAkoya Biosciences$81.67M0.84-$55.37M-$0.97-1.41Quanterix$133.92M2.56-$38.53M-$1.30-5.29 Which has more risk and volatility, AKYA or QTRX? Akoya Biosciences has a beta of 1.36, suggesting that its share price is 36% more volatile than the S&P 500. Comparatively, Quanterix has a beta of 1.13, suggesting that its share price is 13% more volatile than the S&P 500. Do analysts recommend AKYA or QTRX? Akoya Biosciences currently has a consensus price target of $2.51, indicating a potential upside of 83.05%. Quanterix has a consensus price target of $15.60, indicating a potential upside of 126.91%. Given Quanterix's stronger consensus rating and higher possible upside, analysts plainly believe Quanterix is more favorable than Akoya Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Akoya Biosciences 0 Sell rating(s) 7 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Quanterix 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Is AKYA or QTRX more profitable? Quanterix has a net margin of -36.82% compared to Akoya Biosciences' net margin of -59.44%. Quanterix's return on equity of -15.07% beat Akoya Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Akoya Biosciences-59.44% -487.85% -35.86% Quanterix -36.82%-15.07%-12.26% SummaryQuanterix beats Akoya Biosciences on 10 of the 14 factors compared between the two stocks. Get Akoya Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for AKYA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AKYA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AKYA vs. The Competition Export to ExcelMetricAkoya BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$67.94M$2.91B$5.56B$9.04BDividend YieldN/A2.44%5.22%3.99%P/E Ratio-1.4121.5627.6620.25Price / Sales0.84283.36423.00177.43Price / CashN/A42.7336.8958.10Price / Book9.137.518.035.67Net Income-$55.37M-$55.14M$3.18B$249.21M7 Day Performance10.40%4.61%2.93%3.28%1 Month Performance18.02%0.90%1.72%3.95%1 Year Performance-34.50%5.40%34.39%20.98% Akoya Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AKYAAkoya Biosciences2.1279 of 5 stars$1.37+1.4%$2.51+83.1%-34.5%$67.94M$81.67M-1.4190QTRXQuanterix2.0874 of 5 stars$6.30+2.9%$15.60+147.6%-43.8%$237.64M$137.42M-4.85460FEIMFrequency Electronics1.9974 of 5 stars$23.24+9.5%N/A+143.0%$205.34M$55.27M9.64200Analyst DowngradeHigh Trading VolumeRPIDRapid Micro Biosystems1.4819 of 5 stars$3.17-4.5%$8.00+152.4%+471.0%$145.52M$28.05M-3.08200News CoveragePositive NewsSEERSeer2.1138 of 5 stars$1.97-2.0%$3.00+52.3%+38.3%$118.33M$14.17M-1.40160News CoverageOWLTOwlet0.7846 of 5 stars$7.40+4.6%$7.75+4.8%+116.5%$116.83M$78.10M-5.17106PREPrenetics Global1.6746 of 5 stars$8.13-9.3%$9.00+10.7%+34.4%$109.36M$30.62M-2.041Analyst UpgradeHigh Trading VolumeKEQUKewaunee Scientific2.0588 of 5 stars$36.91+0.6%N/A+32.2%$104.73M$203.76M6.251,006News CoverageAnalyst UpgradeNAUTNautilus Biotechnology2.0639 of 5 stars$0.70-2.7%$2.13+205.7%-64.3%$90.16MN/A-1.29130High Trading VolumeINTTinTEST2.9849 of 5 stars$6.92+0.4%$12.00+73.4%-31.5%$86.47M$127.50M30.09320ODYSOdysight.ai1.2018 of 5 stars$4.82-1.8%$10.00+107.5%N/A$80.11M$3.96M-4.7340News CoverageGap Down Related Companies and Tools Related Companies QTRX Competitors FEIM Competitors RPID Competitors SEER Competitors OWLT Competitors PRE Competitors KEQU Competitors NAUT Competitors INTT Competitors ODYS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AKYA) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredJuly 4th: 59% dividend from Bitcoin (No Crypto Needed)I've got something exciting for you this July 4th holiday... How about a 59.07% dividend from Bitcoin? Y...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akoya Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akoya Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
